Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma
Authors:
- Ahter D. SanliogluASAhter D. Sanlioglu
- Bahri KaracayBKBahri Karacay
- Thomas S. GriffithTGThomas S. Griffith
- Salih SanliogluSSSalih Sanlioglu
- 1 March 2008
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 26 (2) , 158-165
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Differential PTEN Protein Expression Profiles in Superficial versus Invasive Bladder CancersUrologia Internationalis, 2005
- The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinomaUrologic Oncology: Seminars and Original Investigations, 2004
- Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinomaLung Cancer, 2004
- Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millenniumUrology, 2001
- Discrepancy between Gleason Scores of Biopsy and Radical Prostatectomy SpecimensEuropean Urology, 2000
- Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987